In this study, researchers explored disparities in metastatic cutaneous melanoma survival following the introduction of immunotherapies.

Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or ...

About 10% of adolescents and young adults treated for solid tumors have a metastatic recurrence, with 5-year rates surpassing ...

Obesity is known to increase the risk of developing many different types of cancer. It’s also associated with worse outcomes in several cancers but improved outcomes in others (in what has been dubbed ...

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients ...

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma Patients (N = 119) with ≥one ...

Dermatomyositis is an autoimmune inflammatory muscle disease that is linked to cancer in approximately one third of the cases. The most commonly associated cancers are ovarian, lung, gastric, ...

Malignant melanoma is a type of skin cancer that originates in melanocytes. Although these pigment-producing cells are found primarily in the basal layer of the skin, they are also located in the GI ...